385 related articles for article (PubMed ID: 8758204)
1. How to differentiate between T-cell-rich B-cell lymphoma and lymphocyte-predominant Hodgkin's disease. Evidence for the value of MB1 and 4KB5 immunostaining.
Schmidt U; Herbst J; Metz KA; Leder LD
J Pathol; 1996 Jun; 179(2):138-44. PubMed ID: 8758204
[TBL] [Abstract][Full Text] [Related]
2. Histiocyte-rich B-cell lymphoma. A distinct clinicopathologic entity possibly related to lymphocyte predominant Hodgkin's disease, paragranuloma subtype.
Delabie J; Vandenberghe E; Kennes C; Verhoef G; Foschini MP; Stul M; Cassiman JJ; De Wolf-Peeters C
Am J Surg Pathol; 1992 Jan; 16(1):37-48. PubMed ID: 1728195
[TBL] [Abstract][Full Text] [Related]
3. Differential diagnosis of L26-positive, CD15-negative Hodgkin's disease and large B-cell lymphoma with a high content of reactive T-cells: a morphologic and immunohistochemical study.
Nguyen DT; Diamond LW; Hansmann ML; Fischer R
Hematopathol Mol Hematol; 1996; 10(3):135-50. PubMed ID: 8878732
[TBL] [Abstract][Full Text] [Related]
4. Use of monoclonal antibodies for the typing of malignant lymphomas in routinely processed biopsy samples.
Lauritzen AF; Ralfkiaer E
APMIS; 1991 Jul; 99(7):631-9. PubMed ID: 2069805
[TBL] [Abstract][Full Text] [Related]
5. T-cell-rich B-cell lymphomas. A clinicopathologic study of 19 cases.
Macon WR; Williams ME; Greer JP; Stein RS; Collins RD; Cousar JB
Am J Surg Pathol; 1992 Apr; 16(4):351-63. PubMed ID: 1373580
[TBL] [Abstract][Full Text] [Related]
6. T-bet, a T cell-associated transcription factor, is expressed in Hodgkin's lymphoma.
Dorfman DM; Hwang ES; Shahsafaei A; Glimcher LH
Hum Pathol; 2005 Jan; 36(1):10-5. PubMed ID: 15712176
[TBL] [Abstract][Full Text] [Related]
7. Hodgkin's disease, lymphocyte predominance type, nodular--further evidence for a B cell derivation. L & H variants of Reed-Sternberg cells express L26, a pan B cell marker.
Pinkus GS; Said JW
Am J Pathol; 1988 Nov; 133(2):211-7. PubMed ID: 3263805
[TBL] [Abstract][Full Text] [Related]
8. CD40 ligand is constitutively expressed in a subset of T cell lymphomas and on the microenvironmental reactive T cells of follicular lymphomas and Hodgkin's disease.
Carbone A; Gloghini A; Gruss HJ; Pinto A
Am J Pathol; 1995 Oct; 147(4):912-22. PubMed ID: 7573367
[TBL] [Abstract][Full Text] [Related]
9. The activation profile of tumour-associated reactive T-cells differs in the nodular and diffuse patterns of lymphocyte predominant Hodgkin's disease.
Lin P; Medeiros LJ; Wilder RB; Abruzzo LV; Manning JT; Jones D
Histopathology; 2004 Jun; 44(6):561-9. PubMed ID: 15186271
[TBL] [Abstract][Full Text] [Related]
10. The distinction of Hodgkin's disease from B cell lymphoma.
Warnke RA
Semin Diagn Pathol; 1992 Nov; 9(4):284-90. PubMed ID: 1480850
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical staining of non-Hodgkin's lymphoma in paraffin sections using the MB1 and MT1 monoclonal antibodies.
Dobson CM; Myskow MW; Krajewski AS; Carpenter FH; Horne CH
J Pathol; 1987 Nov; 153(3):203-12. PubMed ID: 3323430
[TBL] [Abstract][Full Text] [Related]
12. Detection of B- and T-cells in paraffin-embedded tissue sections. Diagnostic utility of commercially obtained 4KB5 and UCHL-1.
Clark JR; Williams ME; Swerdlow SH
Am J Clin Pathol; 1990 Jan; 93(1):58-69. PubMed ID: 2403743
[TBL] [Abstract][Full Text] [Related]
13. Antigen preservation in infarcted lymphoid tissue. A novel approach to the infarcted lymph node using monoclonal antibodies effective in routinely processed tissues.
Norton AJ; Ramsay AD; Isaacson PG
Am J Surg Pathol; 1988 Oct; 12(10):759-67. PubMed ID: 3262314
[TBL] [Abstract][Full Text] [Related]
14. [Immunochemical diagnosis of hepatic localizations in malignant lymphoid hematologic diseases. Study of 80 cases].
Voigt JJ; Vinel JP; Caverivière P; Pradère B; Chittal S; al Saati T; Calès P; Delsol G
Gastroenterol Clin Biol; 1989 Apr; 13(4):343-52. PubMed ID: 2661293
[TBL] [Abstract][Full Text] [Related]
15. [T-cell-rich B-cell lymphoma: multifactorial study of 4 cases].
Moreno MM; Fernández-Flores A; Paradela A; Rodríguez JM; Ageitos A; Gonzalo I; Marcos B; Robledo M; Rivas C
Sangre (Barc); 1995 Dec; 40(6):471-7. PubMed ID: 8850230
[TBL] [Abstract][Full Text] [Related]
16. Differential diagnosis between classic Hodgkin's lymphoma, T-cell-rich B-cell lymphoma, and paragranuloma by paraffin immunohistochemistry.
Rüdiger T; Ott G; Ott MM; Müller-Deubert SM; Müller-Hermelink HK
Am J Surg Pathol; 1998 Oct; 22(10):1184-91. PubMed ID: 9777980
[TBL] [Abstract][Full Text] [Related]
17. Immunohistological analysis of the immunoreactivity of normal lymphoid cells and lymphomas with the monoclonal antibody OPD4.
O'Grady J; Blaikie AJ; Howie SE; Salter DM; Krajewski AS
J Pathol; 1991 Jun; 164(2):119-25. PubMed ID: 2072211
[TBL] [Abstract][Full Text] [Related]
18. Leukocyte-specific phosphoprotein-1 and PU.1: two useful markers for distinguishing T-cell-rich B-cell lymphoma from lymphocyte-predominant Hodgkin's disease.
Marafioti T; Mancini C; Ascani S; Sabattini E; Zinzani PL; Pozzobon M; Pulford K; Falini B; Jaffe ES; Müller-Hermelink HK; Mason DY; Pileri SA
Haematologica; 2004 Aug; 89(8):957-64. PubMed ID: 15339679
[TBL] [Abstract][Full Text] [Related]
19. Correlation of high numbers of intratumoral FOXP3+ regulatory T cells with improved survival in germinal center-like diffuse large B-cell lymphoma, follicular lymphoma and classical Hodgkin's lymphoma.
Tzankov A; Meier C; Hirschmann P; Went P; Pileri SA; Dirnhofer S
Haematologica; 2008 Feb; 93(2):193-200. PubMed ID: 18223287
[TBL] [Abstract][Full Text] [Related]
20. T-cell/histiocyte-rich large B-cell lymphoma is a disseminated aggressive neoplasm: differential diagnosis from Hodgkin's lymphoma.
Fraga M; Sánchez-Verde L; Forteza J; García-Rivero A; Piris MA
Histopathology; 2002 Sep; 41(3):216-29. PubMed ID: 12207783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
